These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38961817)
41. An Open Label, Prospective, Single Centre Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Rabeprazole (Enteric-Coated, EC) 20 mg + Domperidone (Sustained Release, SR) 30 mg Capsule in Treatment of Patients with Laryngopharyngeal Reflux Disease. Semmanaselvan K; Mukaddam QI; Naik M J Assoc Physicians India; 2015 Jul; 63(7):27-32. PubMed ID: 26731824 [TBL] [Abstract][Full Text] [Related]
42. Efficacy of super high dose proton pump inhibitor administration in refractory laryngopharyngeal reflux: a pilot study. Portnoy JE; Gregory ND; Cerulli CE; Hawkshaw MJ; Lurie D; Katz PO; Sataloff RT J Voice; 2014 May; 28(3):369-77. PubMed ID: 24495427 [TBL] [Abstract][Full Text] [Related]
44. Comparison of Reflux Symptom Score versus Reflux Symptom Index in screening laryngopharyngeal reflux. Zhang C; Liu Z; Zhang J; Wang X; Wang J; Zhao J; Li J; Liu L Laryngoscope; 2023 Sep; 133(9):2104-2109. PubMed ID: 36453478 [TBL] [Abstract][Full Text] [Related]
45. Is empirical treatment a reasonable strategy for laryngopharyngeal reflux? A contemporary review. Lechien JR; Bock JM; Carroll TL; Akst LM Clin Otolaryngol; 2020 Jul; 45(4):450-458. PubMed ID: 32097534 [TBL] [Abstract][Full Text] [Related]
46. Empirical treatment with pantoprazole as a diagnostic tool for symptomatic adult laryngopharyngeal reflux. Masaany M; Marina MB; Sharifa Ezat WP; Sani A J Laryngol Otol; 2011 May; 125(5):502-8. PubMed ID: 21356141 [TBL] [Abstract][Full Text] [Related]
47. Reflux Symptom Index and Reflux Finding Score in Diagnosis of Laryngopharyngeal Reflux. Pokharel M; Shrestha I; Dhakal A; Purbey B; Amatya RC Kathmandu Univ Med J (KUMJ); 2016 Oct.-Dec.; 14(56):332-336. PubMed ID: 29336421 [TBL] [Abstract][Full Text] [Related]
48. Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease: a prospective multicenter study. Lee YC; Lee JS; Kim SW; Kwon KH; Eun YG JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1291-5. PubMed ID: 24201320 [TBL] [Abstract][Full Text] [Related]
49. Dual pH with Multichannel Intraluminal Impedance Testing in the Evaluation of Subjective Laryngopharyngeal Reflux Symptoms. Cumpston EC; Blumin JH; Bock JM Otolaryngol Head Neck Surg; 2016 Dec; 155(6):1014-1020. PubMed ID: 27554506 [TBL] [Abstract][Full Text] [Related]
51. Relationship between laryngopharyngeal reflux disease and gastroesophageal reflux disease based on synchronous esophageal and oropharyngeal Dx-pH monitoring. Wang L; Wang G; Li L; Fan X; Liu H; Sun Z; Han H; Li B; Ding R; Wu W Am J Otolaryngol; 2020; 41(3):102441. PubMed ID: 32144021 [TBL] [Abstract][Full Text] [Related]
52. Management of laryngopharyngeal reflux in Brazil: a national survey. Lechien JR; Perazzo PS; Ceccon FP; Eckley CA; Lopes KC; Maunsell R; Avelino MAG; Akst LM; Sant'Anna GD; Imamura R Braz J Otorhinolaryngol; 2022; 88(6):850-857. PubMed ID: 33461911 [TBL] [Abstract][Full Text] [Related]
53. Role of Pepsin and Oropharyngeal pH-Monitoring to Assess the Postoperative Outcome of Patients with Laryngopharyngeal Reflux: Results of a Pilot Trial. Weitzendorfer M; Pfandner R; Antoniou SA; Langsteger W; Witzel K; Emmanuel K; Koch OO J Laparoendosc Adv Surg Tech A; 2017 Sep; 27(9):937-943. PubMed ID: 28731842 [TBL] [Abstract][Full Text] [Related]
54. Sensitivity, Specificity, and Predictive Values of Laryngopharyngeal Reflux Symptoms and Signs in Clinical Practice. Lechien JR Otolaryngol Head Neck Surg; 2023 Jul; 169(1):97-104. PubMed ID: 36040820 [TBL] [Abstract][Full Text] [Related]
55. [The prevalence and relationship between laryngopharyngeal reflux disease, anxiety and depression in otolaryngology outpatients]. Li CF; Zhang LH; Wang WL; Cao J; Wang YG; Zhao YX Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Mar; 55(3):241-248. PubMed ID: 32268693 [No Abstract] [Full Text] [Related]
56. Nissen fundoplication Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691 [TBL] [Abstract][Full Text] [Related]
57. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422 [TBL] [Abstract][Full Text] [Related]
58. Digestive Biomarkers of Laryngopharyngeal Reflux: A Preliminary Prospective Controlled Study. Lechien JR; De Marrez LG; Hans S; Muls V; Spinato L; Briganti G; Saussez S; De Vos N Otolaryngol Head Neck Surg; 2024 May; 170(5):1364-1371. PubMed ID: 38353373 [TBL] [Abstract][Full Text] [Related]
59. Upper Esophageal Sphincter Compression Device as an Adjunct to Proton Pump Inhibition for Laryngopharyngeal Reflux. Yadlapati R; Pandolfino JE; Greytak M; Cahoon J; Clarke M; Clary M; Fink D; Menard-Katcher P; Vahabzadeh-Hagh AM; Weissbrod P; Gupta S; Kaizer A; Wani S Dig Dis Sci; 2022 Jul; 67(7):3045-3054. PubMed ID: 34275061 [TBL] [Abstract][Full Text] [Related]
60. First agreement analysis and day-to-day comparison of pharyngeal pH monitoring with pH/impedance monitoring in patients with suspected laryngopharyngeal reflux. Becker V; Graf S; Schlag C; Schuster T; Feussner H; Schmid RM; Bajbouj M J Gastrointest Surg; 2012 Jun; 16(6):1096-101. PubMed ID: 22450948 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]